173 related articles for article (PubMed ID: 36781419)
21. Acalabrutinib and steroid for autoimmune thrombocytopenia due to relapsed chronic lymphocytic leukemia with severe bone marrow infiltration.
Oyama T; Yasunaga M; Jona M; Nishikawa M; Yatomi Y; Honda A; Maki H; Morita K; Masamoto Y; Kurokawa M
J Clin Exp Hematop; 2023 Sep; 63(3):187-192. PubMed ID: 37635085
[TBL] [Abstract][Full Text] [Related]
22. Chronic lymphocytic leukemia-associated refractory immune thrombocytopenia successfully treated with eltrombopag.
Chang H; Shih LY
Tumori; 2015 Apr; 101(2):e49-50. PubMed ID: 25702666
[TBL] [Abstract][Full Text] [Related]
23. Immune-mediated hemolytic anemia and thrombocytopenia in clonal B-cell disorders: a review.
Durani U; Go RS; Kay NE
Clin Adv Hematol Oncol; 2018 Oct; 16(10):670-676. PubMed ID: 30543597
[TBL] [Abstract][Full Text] [Related]
24. Treatment patterns and outcomes of second-line rituximab and thrombopoietin receptor agonists in adult immune thrombocytopenia: A Canadian retrospective cohort study.
Podstawka J; Wall E; Bolster L; Patterson JM; Goodyear MD; Rydz N; Sun HL
Thromb Res; 2022 Dec; 220():5-11. PubMed ID: 36257098
[TBL] [Abstract][Full Text] [Related]
25. Pathogenesis, prevalence, and prognostic significance of cytopenias in chronic lymphocytic leukemia (CLL): a retrospective comparative study of 213 patients from a national CLL database of 1,518 cases.
Shvidel L; Tadmor T; Braester A; Bairey O; Rahimi-Levene N; Herishanu Y; Klepfish A; Shtalrid M; Berrebi A; Polliack A;
Ann Hematol; 2013 May; 92(5):661-7. PubMed ID: 23274356
[TBL] [Abstract][Full Text] [Related]
26. Recognizing and treating secondary immune thrombocytopenic purpura associated with lymphoproliferative disorders.
Liebman HA
Semin Hematol; 2009 Jan; 46(1 Suppl 2):S33-6. PubMed ID: 19245932
[TBL] [Abstract][Full Text] [Related]
27. Autoimmune cytopenias in chronic lymphocytic leukemia.
Visco C; Barcellini W; Maura F; Neri A; Cortelezzi A; Rodeghiero F
Am J Hematol; 2014 Nov; 89(11):1055-62. PubMed ID: 24912821
[TBL] [Abstract][Full Text] [Related]
28. Management of major bleeds in patients with immune thrombocytopenia.
Mithoowani S; Cervi A; Shah N; Ejaz R; Sirotich E; Barty R; Li N; Nazy I; Arnold DM
J Thromb Haemost; 2020 Jul; 18(7):1783-1790. PubMed ID: 32219982
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic plasma exchange practices in immune thrombocytopenia related hospitalizations: Results from a nationally representative sample.
Makhani SS; Schwartz J; Vasovic LV; DeSimone RA; Kaicker S; Bussel J; Crowe EP; Bloch EM; Tobian AAR; Goel R
J Clin Apher; 2022 Oct; 37(5):507-511. PubMed ID: 35979873
[TBL] [Abstract][Full Text] [Related]
30. Idiopathic thrombocytopenic purpura is strongly associated with higher prevalence of aortic valve disease.
Haseefa F; Movahed MR; Hashemzadeh M; Hashemzadeh M
Ann Hematol; 2020 Sep; 99(9):2081-2084. PubMed ID: 32691113
[TBL] [Abstract][Full Text] [Related]
31. Temporal Trends of Intracranial Hemorrhage Among Immune Thrombocytopenia Hospitalizations in the United States.
Bhatt P; Yagnik PJ; Ayensu M; Khan AW; Adjei A; Parmar N; Bhal K; Donda K; Dapaah-Siakwan F; Bhatt NS
Cureus; 2020 Jul; 12(7):e9427. PubMed ID: 32864253
[TBL] [Abstract][Full Text] [Related]
32. Management of immune thrombocytopenia in adults: a population-based analysis of the French hospital discharge database from 2009 to 2012.
Michel M; Suzan F; Adoue D; Bordessoule D; Marolleau JP; Viallard JF; Godeau B
Br J Haematol; 2015 Jul; 170(2):218-22. PubMed ID: 25824587
[TBL] [Abstract][Full Text] [Related]
33. Older Adults and Immune Thrombocytopenia: Considerations for the Clinician.
Crickx E; Mahévas M; Michel M; Godeau B
Clin Interv Aging; 2023; 18():115-130. PubMed ID: 36726813
[TBL] [Abstract][Full Text] [Related]
34. Life-threatening bleeding episodes in primary immune thrombocytopenia: a single-center retrospective study of 169 inpatients.
Tsuda H; Tsuji T; Tsuji M; Yamasaki H
Ann Hematol; 2017 Nov; 96(11):1915-1920. PubMed ID: 28808759
[TBL] [Abstract][Full Text] [Related]
35. Rituximab treatment of refractory fludarabine-associated immune thrombocytopenia in chronic lymphocytic leukemia.
Hegde UP; Wilson WH; White T; Cheson BD
Blood; 2002 Sep; 100(6):2260-2. PubMed ID: 12200396
[TBL] [Abstract][Full Text] [Related]
36. Low-dose alemtuzumab-associated immune thrombocytopenia in chronic lymphocytic leukemia.
Reda G; Maura F; Gritti G; Gregorini A; Binda F; Guidotti F; Piciocchi A; Visco C; Rodeghiero F; Cortelezzi A
Am J Hematol; 2012 Sep; 87(9):936-7. PubMed ID: 22718434
[TBL] [Abstract][Full Text] [Related]
37. Cost and mortality associated with hospitalizations in patients with immune thrombocytopenic purpura.
Danese MD; Lindquist K; Gleeson M; Deuson R; Mikhael J
Am J Hematol; 2009 Oct; 84(10):631-5. PubMed ID: 19705429
[TBL] [Abstract][Full Text] [Related]
38. Primary immune thrombocytopenia in very elderly patients: particularities in presentation and management: results from the prospective CARMEN-France Registry.
Sokal A; de Nadaï T; Maquet J; Comont T; Limal N; Michel M; Beyne-Rauzy O; Godeau B; Adoue D; Mahévas M; Moulis G;
Br J Haematol; 2022 Mar; 196(5):1262-1270. PubMed ID: 34738634
[TBL] [Abstract][Full Text] [Related]
39. [Diagnostic approach and treatment of immune thrombocytopenia in adults].
Kolonić SO; Patekar MB; Milunović V
Acta Med Croatica; 2013 Mar; 67(1):3-11. PubMed ID: 24279250
[TBL] [Abstract][Full Text] [Related]
40. Clinical variations between three different causes of thrombocytopenia.
Akin S; Haznedaroglu IC
Niger J Clin Pract; 2021 Jan; 24(1):17-20. PubMed ID: 33473020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
